172 related articles for article (PubMed ID: 32508457)
1. Qualitative expression of hypoxia-inducible factor-1α in malignant transformation of oral submucous fibrosis: An immunohistochemical study.
Pereira T; Surve R; Shetty S; Gotmare S
J Oral Maxillofac Pathol; 2020; 24(1):106-112. PubMed ID: 32508457
[TBL] [Abstract][Full Text] [Related]
2. The domino effect: Role of hypoxia in malignant transformation of oral submucous fibrosis.
Chaudhary M; Bajaj S; Bohra S; Swastika N; Hande A
J Oral Maxillofac Pathol; 2015; 19(2):122-7. PubMed ID: 26604484
[TBL] [Abstract][Full Text] [Related]
3. HIF - 1α as a marker of risk assessment for malignant transformation in oral submucous fibrosis: An immunohistochemical study.
Sharma K; Shetty DC; Rathore AS; Juneja SA; Katyal S; Krishnatre A
Indian J Pathol Microbiol; 2022; 65(4):761-765. PubMed ID: 36308177
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of HIF-1alpha in malignant transformation of oral submucous fibrosis.
Tilakaratne WM; Iqbal Z; Teh MT; Ariyawardana A; Pitiyage G; Cruchley A; Stewart JE; Hagi-Pavli E; Lalli A; Waseem A; Parkinson EK; Fortune F
J Oral Pathol Med; 2008 Jul; 37(6):372-7. PubMed ID: 18221327
[TBL] [Abstract][Full Text] [Related]
5. Hypoxic regulation of plasminogen activator inhibitor-1 expression in human buccal mucosa fibroblasts stimulated with arecoline.
Tsai CH; Lee SS; Chang YC
J Oral Pathol Med; 2015 Oct; 44(9):669-73. PubMed ID: 25367145
[TBL] [Abstract][Full Text] [Related]
6. Significance of HIF-1α and CD105 in establishing oral squamous cell carcinoma associated with oral submucous fibrosis a distinct clinicopathological entity.
Hande AH; Chaudhary MS; Gadbail AR; Gawande MN; Patil SK; Zade PR; Sharma PN; Jaiswal SG; Sonone AM
J Cancer Res Ther; 2022; 18(1):33-41. PubMed ID: 35381759
[TBL] [Abstract][Full Text] [Related]
7. An enigmatic pathogenetic mechanism of hypoxia inducible factor - 1/2 alpha in the progression of fibrosis of oral submucous fibrosis and its malignant transformation: A systematic review and meta-analysis.
R K; Chandra A; Jain T; Singh N; Agrawal R
Arch Oral Biol; 2024 Jun; 162():105944. PubMed ID: 38492547
[TBL] [Abstract][Full Text] [Related]
8. Study of Hypoxia-inducible factor-2α expression in the malignant transformation of Oral submucous fibrosis.
Joseph I; Elizabeth J; Rao UK; Ranganathan K
J Oral Maxillofac Pathol; 2020; 24(1):33-39. PubMed ID: 32508445
[TBL] [Abstract][Full Text] [Related]
9. Endorsing cellular competitiveness in aberrant epithelium of oral submucous fibrosis progression: neighbourhood analysis of immunohistochemical attributes.
Anura A; Kazi A; Pal M; Paul RR; Sengupta S; Chatterjee J
Histochem Cell Biol; 2018 Jul; 150(1):61-75. PubMed ID: 29687243
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.
Cohen NA; Lai SY; Ziober AF; Ziober BL
Laryngoscope; 2004 Mar; 114(3):418-23. PubMed ID: 15091212
[TBL] [Abstract][Full Text] [Related]
11. Regulation of hypoxia-inducible factor-1α in human buccal mucosal fibroblasts stimulated with arecoline.
Ho YC; Yang SF; Lee SS; Chang YC
J Formos Med Assoc; 2017 Jun; 116(6):484-487. PubMed ID: 28365254
[TBL] [Abstract][Full Text] [Related]
12. The Role of Increased Connective Tissue Growth Factor in the Pathogenesis of Oral Submucous Fibrosis and its Malignant Transformation-An Immunohistochemical Study.
Shah AM; Jain K; Desai RS; Bansal S; Shirsat P; Prasad P; Bodhankar K
Head Neck Pathol; 2021 Sep; 15(3):817-830. PubMed ID: 33544386
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia inducible factor 1α-mediated LOX expression correlates with migration and invasion in epithelial ovarian cancer.
Ji F; Wang Y; Qiu L; Li S; Zhu J; Liang Z; Wan Y; Di W
Int J Oncol; 2013 May; 42(5):1578-88. PubMed ID: 23545606
[TBL] [Abstract][Full Text] [Related]
14. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
[TBL] [Abstract][Full Text] [Related]
15. Malignant transformation of oral submucous fibrosis: overview of histopathological aspects.
Ray JG; Ranganathan K; Chattopadhyay A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Aug; 122(2):200-9. PubMed ID: 27422418
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of syndecan-1 in leukoplakia and oral submucous fibrosis.
Kamat SS; Kumar GS; Koshy AV
Dent Res J (Isfahan); 2013 May; 10(3):321-7. PubMed ID: 24019799
[TBL] [Abstract][Full Text] [Related]
17. Interplay of Transforming Growth Factor-Beta 1 and 3 in the Pathogenesis of Oral Submucous Fibrosis and Its Malignant Transformation: An Immunohistochemical Study.
Bansal S; Pereira T; Desai RS; Jena A; Bobade PP; Patil M
Cureus; 2023 Jul; 15(7):e42412. PubMed ID: 37637625
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms and markers of malignant transformation of oral submucous fibrosis.
Lin F; Xiao T; Wang B; Wang L; Liu G; Wang R; Xie C; Tang Z
Heliyon; 2024 Jan; 10(1):e23314. PubMed ID: 38163180
[TBL] [Abstract][Full Text] [Related]
19. Lenticular cytoprotection. Part 1: the role of hypoxia inducible factors-1α and -2α and vascular endothelial growth factor in lens epithelial cell survival in hypoxia.
Neelam S; Brooks MM; Cammarata PR
Mol Vis; 2013; 19():1-15. PubMed ID: 23335846
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor-1α and glucose transporter 1 in the malignant transformation of oral lichen planus.
Wang XX; Sun HY; Yang QZ; Guo B; Sai Y; Zhang J
Int J Clin Exp Pathol; 2017; 10(8):8369-8376. PubMed ID: 31966688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
